✦ LIBER ✦

Superficial soft tissue sarcomas (S-STS): A study of 367 patients from the French Sarcoma Group (FSG) database

✍ Scribed by Sébastien Salas; Eberhard Stoeckle; Françoise Collin; Binh Bui; Philippe Terrier; Louis Guillou; Martine Trassard; Dominique Ranchere-Vince; Fleur Gregoire; Jean-Michel Coindre

Book ID: 116430010
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 734 KB
Volume: 45
Category: Article
ISSN: 0959-8049
DOI: 10.1016/j.ejca.2009.03.006

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Chemotherapy in patients with desmoid tu

Chemotherapy in patients with desmoid tumors: a study from the French Sarcoma Group (FSG)

✍ Garbay, D.; Le Cesne, A.; Penel, N.; Chevreau, C.; Marec-Berard, P.; Blay, J.- Y 📂 Article 📅 2012 🏛 Oxford University Press 🌐 English ⚖ 140 KB

Temozolomide in adult patients with adva

Temozolomide in adult patients with advanced soft tissue sarcoma: a phase II study of the EORTC Soft Tissue and Bone Sarcoma Group

✍ P.J Woll; I Judson; S.M Lee; S Rodenhuis; O.S Nielsen; J.M Buesa; P.C Lorigan; S 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 51 KB

Performance status is the most powerful

Performance status is the most powerful risk factor for early death among patients with advanced soft tissue sarcomaThe European Organisation for Research and Treatment of Cancer – Soft Tissue and Bone Sarcoma Group (STBSG) and French Sarcoma Group (FSG) study

✍ Penel, N; Glabbeke, M V; Mathoulin-Pelissier, S; Judson, I; Sleijfer, S; Bui, B; 📂 Article 📅 2011 🏛 Nature Publishing Group 🌐 English ⚖ 356 KB

Pemetrexed in patients with refractory s

Pemetrexed in patients with refractory soft tissue sarcoma: A non-comparative multicenter phase II study of the German Sarcoma Group AIO-STS 005

✍ J. T. Hartmann, S. Bauer, G. Egerer, M. S. Horger, H.-G. Kopp, V. Grünwald, F. M 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 255 KB

Exatecan in pretreated adult patients wi

Exatecan in pretreated adult patients with advanced soft tissue sarcoma: Results of a phase II – Study of the EORTC Soft Tissue and Bone Sarcoma Group

✍ P. Reichardt; O.S. Nielsen; S. Bauer; J.T. Hartmann; P. Schöffski; T.B. Christen 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 154 KB

Adjuvant treatment of GIST with imatinib

Adjuvant treatment of GIST with imatinib: Solid ground or still quicksand? A comment on behalf of the EORTC Soft Tissue and Bone Sarcoma Group, the Italian Sarcoma Group, the NCRI Sarcoma Clinical Studies Group (UK), the Japanese Study Group on GIST, the French Sarcoma Group and the Spanish Sarcoma Group (GEIS)

✍ Alessandro Gronchi; Ian Judson; Toshirou Nishida; Andres Poveda; Javier Martin; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 102 KB